Here is how to respond if outcomes don't match expectations
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hassler S. 1994. Bioteeh goes to trial. Bio/Technology 12: 55
See e.g., Tanouye Elyse. Is bioteeh going bust by rushing clinical trials? Wall St. J. July 21, 1994, pg. B1; Hamilton, J. Bioteeh. Bus. Wi., Sept. 26, 1994, pg. 84.
In early March of this year it was announced that Synergen had reached a $28 million settlement with a class of shareholders who purchased stock between November 1991 and February 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Egan, J., Cronan, R. & Johnson, J. Managing a Crisis in Clinical Trials. Nat Biotechnol 13, 559–561 (1995). https://doi.org/10.1038/nbt0695-559
Issue Date:
DOI: https://doi.org/10.1038/nbt0695-559